AKALINX Trademark

Trademark Overview

On Wednesday, April 4, 2012, a trademark application was filed for AKALINX with the United States Patent and Trademark Office. The USPTO has given the AKALINX trademark a serial number of 79113300. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, April 4, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The AKALINX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
akalinx

General Information

Serial Number79113300
Word MarkAKALINX
Filing DateWednesday, April 4, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, April 4, 2022
Registration Number4252232
Registration DateTuesday, December 4, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Sunday, October 30, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, October 30, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, June 19, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, May 21, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, May 21, 2020INVALIDATION PROCESSED
Thursday, March 5, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 5, 2019CANCELLED SECTION 71
Monday, April 8, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 16, 2013FINAL DISPOSITION NOTICE SENT TO IB
Saturday, March 16, 2013FINAL DISPOSITION PROCESSED
Monday, March 4, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 4, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, October 16, 2012NOTIFICATION PROCESSED BY IB
Tuesday, September 18, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 29, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 29, 2012NOTICE OF PUBLICATION
Tuesday, August 14, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 14, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 14, 2012DATA MODIFICATION COMPLETED
Monday, August 13, 2012AMENDMENT FROM APPLICANT ENTERED
Monday, August 13, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 28, 2012REFUSAL PROCESSED BY IB
Friday, July 27, 2012ASSIGNED TO LIE
Tuesday, July 24, 2012PAPER RECEIVED
Thursday, July 12, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 6, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 6, 2012REFUSAL PROCESSED BY MPU
Friday, July 6, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 5, 2012NON-FINAL ACTION WRITTEN
Tuesday, July 3, 2012APPLICATION FILING RECEIPT MAILED
Monday, July 2, 2012ASSIGNED TO EXAMINER
Thursday, June 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 26, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, June 22, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

akalinx system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary